Litigation

ModernaTX, Inc. v. Arbutus Biopharma Corporation

affirmed; mandate issued

2020-2329

Auto-generating section 1 of 4: Case overview & background…

Each section takes ~30-60s with web-search grounding. Keep this tab open — sections will fill in below as they complete.

Filed
2020-09-25
Terminated
2022-01-10

Patents at issue (1)

8058069

Plaintiffs (1)

Summary

ModernaTX appealed the PTAB's IPR2019-00554 Final Written Decision on U.S. 8,058,069. The Federal Circuit docketed the appeal on Sept. 25, 2020, heard argument Oct. 7, 2021 (jointly with the companion '435 appeal, No. 20-1184), and affirmed on Dec. 1, 2021; mandate issued Jan. 10, 2022.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).